Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin in Acute Pneumonia in the Elderly
NCT06774846Phase 3Not yet recruiting
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Jul 2028
- Primary completion
- Oct 2031
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial of aspirin (2 arms), sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Primary endpoint: Overall Survival at 90 days. Planned start Jul 2028; status: not yet recruiting.
02
Drugs
aspirin
Beyond the preview
Go deeper on NCT06774846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06774846.